Aquestive Therapeutics (AQST) Other Operating Expenses (2017 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Other Operating Expenses of $3.5 million for Q1 2026, down 5.01% year-over-year from $3.7 million in Q1 2025, and down 40.56% quarter-over-quarter from $5.8 million in Q4 2025.
Aquestive Therapeutics (AQST) Other Operating Expenses (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' Other Operating Expenses history runs 10 years deep, the most recent figure standing at $3.5 million for Q1 2026.
- In Q1 2026, Other Operating Expenses fell 5.01% year-over-year to $3.5 million; the TTM figure through Mar 2026 stood at $18.4 million (up 7.22% YoY), while the FY2025 annual figure was $18.6 million, up 3.82% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $3.5 million, down from $5.8 million in the prior quarter.
- The five-year high for Other Operating Expenses was $6.6 million in Q2 2023, with the low at $3.5 million in Q1 2026.
- The 5-year median for Other Operating Expenses is $4.6 million (2025), against an average of $4.7 million.
- The sharpest annual moves came in 2022 and 2024: Other Operating Expenses jumped 57.61% in 2022, then slumped 31.6% in 2024.
- Aquestive Therapeutics' Other Operating Expenses stood at $5.3 million in 2022, then dropped by 11.8% to $4.7 million in 2023, then retreated by 3.4% to $4.5 million in 2024, then grew by 29.12% to $5.8 million in 2025, then plunged by 40.56% to $3.5 million in 2026.
- Business Quant data shows AQST's Other Operating Expenses at $3.5 million in Q1 2026, $5.8 million in Q4 2025, and $4.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Aquestive Therapeutics | 560.60 Mn | 560.60 Mn | 9.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.02 Mn |
| Mar 31, 2026 | 3.47 Mn |
| Dec 31, 2025 | 5.84 Mn |
| Sep 30, 2025 | 4.51 Mn |
| Jun 30, 2025 | 4.56 Mn |
| Mar 31, 2025 | 3.65 Mn |
| Dec 31, 2024 | 4.52 Mn |
| Sep 30, 2024 | 4.44 Mn |
| Jun 30, 2024 | 4.53 Mn |
| Mar 31, 2024 | 4.39 Mn |
| Dec 31, 2023 | 4.68 Mn |
| Sep 30, 2023 | 4.80 Mn |
| Jun 30, 2023 | 6.62 Mn |
| Mar 31, 2023 | 4.74 Mn |
| Dec 31, 2022 | 5.31 Mn |
| Sep 30, 2022 | 4.63 Mn |
| Jun 30, 2022 | 5.24 Mn |
| Mar 31, 2022 | 4.21 Mn |
| Dec 31, 2021 | 3.37 Mn |
| Sep 30, 2021 | 4.40 Mn |